Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSL | Sydney | Healthcare | Pharmaceuticals | A$143.29B | 36.3x | 1.77 | A$295.78 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.9% Upside | Upgrade to Pro+ | |
Resmed DRC | Sydney | Healthcare | Healthcare Equipment & Supplies | A$51.77B | 34.3x | 2.44 | A$35.20 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Fisher&Paykel Healthcare | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.67B | 160.9x | -3.23 | A$33.38 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.4% Upside | Upgrade to Pro+ | |
Pro Medicus Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.48B | 235.4x | 6.31 | A$186.23 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -25.2% Downside | Upgrade to Pro+ | |
Cochlear | Sydney | Healthcare | Healthcare Equipment & Supplies | A$19.11B | 53.5x | 2.83 | A$292.07 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.6% Upside | Upgrade to Pro+ | |
Sonic Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$13.02B | 25.5x | -0.97 | A$27.18 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3% Downside | Upgrade to Pro+ | |
Ramsay Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$9.77B | 11.2x | 0.19 | A$42.67 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4% Upside | Upgrade to Pro+ | |
Ramsay Health Care Pref | Sydney | Healthcare | Healthcare Providers & Services | A$9.77B | 11.2x | A$105 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$7.13B | 139.4x | 0.7 | A$21.22 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.8% Upside | Upgrade to Pro+ | |
Ebos | Sydney | Healthcare | Pharmaceuticals | A$6.59B | 23.6x | 3.76 | A$33.70 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.2% Upside | Upgrade to Pro+ | |
Ansell | Sydney | Healthcare | Healthcare Equipment & Supplies | A$4.65B | 36.4x | -0.84 | A$32.11 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Sigma Pharma | Sydney | Healthcare | Pharmaceuticals | A$2.92B | -940x | 9.01 | A$1.86 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.9% Downside | Upgrade to Pro+ | |
Summerset Group | Sydney | Healthcare | Healthcare Providers & Services | A$2.60B | 7x | 0.14 | A$11 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$2.28B | -44.3x | 0.93 | A$6.97 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.1% Upside | Upgrade to Pro+ | |
Regis Healthcare Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$1.95B | -91.1x | -3.64 | A$6.47 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.9% Upside | Upgrade to Pro+ | |
Neuren Pharma | Sydney | Healthcare | Pharmaceuticals | A$1.65B | 14.4x | 0.14 | A$12.94 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Polynovo | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.65B | 301.3x | 1.61 | A$2.39 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$1.64B | -10.5x | -0.87 | A$1.45 | 4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
Primary Health Care | Sydney | Healthcare | Healthcare Providers & Services | A$1.25B | -1.8x | 0.04 | A$1.73 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.9% Downside | Upgrade to Pro+ | |
Opthea | Sydney | Healthcare | Biotechnology & Medical Research | A$1.12B | -1.7x | 0.48 | A$0.91 | 4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.6% Downside | Upgrade to Pro+ | |
Nanosonics | Sydney | Healthcare | Healthcare Equipment & Supplies | A$1.07B | 84.4x | -2.42 | A$3.53 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.5% Downside | Upgrade to Pro+ | |
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$933.22M | -18.2x | 0.6 | A$0.20 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Paragon Care Ltd | Sydney | Healthcare | Healthcare Equipment & Supplies | A$802.82M | 53.3x | -2.79 | A$0.49 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Australian Clinical Labs | Sydney | Healthcare | Healthcare Providers & Services | A$756.23M | 28.2x | -0.95 | A$3.75 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -7.4% Downside | Upgrade to Pro+ | |
Integral Diagnostics Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$715.78M | -11.9x | 0.03 | A$3.08 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 0.2% Upside | Upgrade to Pro+ | |
Clinuvel Pharmaceuticals | Sydney | Healthcare | Pharmaceuticals | A$702.25M | 19.5x | 1.1 | A$14.12 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Botanix Pharma | Sydney | Healthcare | Pharmaceuticals | A$667.57M | -42.6x | 3.02 | A$0.37 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Oceania Healthcare | Sydney | Healthcare | Healthcare Providers & Services | A$532.31M | 18.5x | 0.19 | A$0.74 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Monash IVF Group Ltd | Sydney | Healthcare | Healthcare Providers & Services | A$471.46M | -71.5x | 0.56 | A$1.21 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23% Upside | Upgrade to Pro+ | |
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$465.46M | -8.9x | -0.52 | A$0.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |